Rating History for BridgeBio Pharma (BBIO) by Raymond James
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/26/2026 | Martin Auster | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
70.28 (81.38) |
15.79% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
